Skip to main content
. 2021 Jul 16;478(13):2697–2713. doi: 10.1042/BCJ20210172

Figure 8. Activity of PfA-M17, Pv-M17 and Pb-M17 against hemoglobin-derived hexapeptide and alanine screen peptides.

Figure 8.

Activity of PfA-M17 (A), Pv-M17 (B) and Pb-M17 (C) against hemoglobin derived hexapeptide, LDPENF, and alanine screen peptides, ADPENF, LAPENF, LDAENF, LDPANF, LDPEAF and LDPENA. Activity presented as percentage of peptide cleaved at the P1 position. Dashed line represents activity against template peptide LDPENF. Experiments were carried out in technical duplicate. Squares represent duplicate mean and error bars represent duplicate range.